Analytical Data
-
Gene name
CLUL1
- Application
-
Alternative Names
CLUL1；Clusterin-like Protein 1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q15846
-
Expression Region
21-466aa
-
AA Sequence
APTWKDKTAI SENLKSFSEV GEIDADEEVK KALTGIKQMK IMMERKEKEH TNLMSTLKKC REEKQEALKL LNEVQEHLEE EERLCRESLA DSWGECRSCL ENNCMRIYTT CQPSWSSVKN KIERFFRKIY QFLFPFHEDN EKDLPISEKL IEEDAQLTQM EDVFSQLTVD VNSLFNRSFN VFRQMQQEFD QTFQSHFISD TDLTEPYFFP AFSKEPMTKA DLEQCWDIPN FFQLFCNFSV SIYESVSETI TKMLKAIEDL PKQDKAPDHG GLISKMLPGQ DRGLCGELDQ NLSRCFKFHE KCQKCQAHLS EDCPDVPALH TELDEAIRLV NVSNQQYGQI LQMTRKHLED TAYLVEKMRG QFGWVSELAN QAPETEIIFN SIQVVPRIHE GNISKQDETM MTDLSILPSS NFTLKIPLEE SAESSNFIGY VVAKALQHFK EHFKTW
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CLUL1, a member of the C-type lectin family, has garnered significant attention in recent years due to its potential roles in immune response and pathogen recognition. Studies indicate that CLUL1 might be involved in mediating interactions between host cells and various pathogens, including viruses and bacteria, which positions it as a critical player in the innate immune system. Its carbohydrate-binding properties suggest that CLUL1 could facilitate the identification of glycosylated molecules on pathogens, triggering immune responses. Furthermore, the exploration of CLUL1 as a recombinant protein has opened avenues for understanding its structure-function relationship and its potential therapeutic applications. As advances in protein engineering techniques allow for the production of recombinant CLUL1, research into its specific binding affinities and downstream effects on immune signaling pathways is gaining momentum. Understanding the mechanisms by which CLUL1 operates may provide insights into the development of novel immunotherapies and vaccine strategies. Overall, the study of CLUL1 as a recombinant protein not only enhances our comprehension of its biological significance but also paves the way for innovative approaches in combating infectious diseases.
